Blood flow cuffs or instrument massage: which boosts ACL recovery best?

NCT ID NCT07662850

Recruiting now Disease control Sponsor: Lahore University of Biological and Applied Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 4 times

Summary

This trial tests two rehabilitation methods—blood flow restriction training and instrument-assisted soft tissue mobilization—in people recovering from ACL reconstruction. Both are added to standard physiotherapy to see which better reduces pain, improves knee strength and range of motion, and eases fear of movement. The study involves 46 adults who are 8 to 16 weeks post-surgery and will receive their assigned treatment twice a week for eight weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blood flow restriction training and instrument-assisted soft tissue mobilization
What this could lead to: If one method proves superior, it could become a standard part of ACL rehabilitation, helping people recover strength and mobility faster with less fear of movement.
What could go wrong: This is a small, early-stage trial with only 46 participants, so results may not apply to everyone. Both interventions are adjuncts to standard care, so any benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL RECONSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kinesiophobia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACL RECONSTRUCTION ANTERIOR CRUCIATE LIGAMENT INJURY POSTOPERATIVE KNEE REHABILITATION

Contacts and locations

Locations

Shareef Medical City Hospital
RECRUITING

Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.